Literature DB >> 8265827

Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis.

E L Alexander1.   

Abstract

There is a growing appreciation that a subset of patients with primary Sjögren's syndrome (SS) also may develop a spectrum of central nervous system (CNS) complications. This article defines SS and its significance; discusses CNS, peripheral nervous system, and muscular complications of SS; identifies those areas in general or internal medicine in which SS patients with potential neurologic complications may present; describes those neurologic disorders that SS may mimic; places into perspective the controversy regarding the frequency and significance of CNS-SS; and extends our observations on the immunopathogenesis of neurologic complications in SS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8265827

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  25 in total

Review 1.  CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors:  M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Central nervous system involvement in Sjogren's syndrome.

Authors:  F C Soliotis; C P Mavragani; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

Review 3.  [Differential diagnosis of chronic inflammatory diseases of the central nervous system. Cerebrospinal fluid diagnosis and immunological parameters].

Authors:  D Reske; H-F Petereit
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

4.  Orofacial dystonia related to Sjogren's syndrome.

Authors:  Sokratis G Papageorgiou; Theodoros Kontaxis; Anastasios Bonakis; Nikolaos Kalfakis
Journal:  Clin Rheumatol       Date:  2007-01-16       Impact factor: 2.980

5.  Recurrent aseptic meningitis: a new CSF complication of Sjogren's syndrome.

Authors:  Kazuyuki Ishida; Toshiki Uchihara; Hidehiro Mizusawa
Journal:  J Neurol       Date:  2007-04-09       Impact factor: 4.849

6.  Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjögren's syndrome.

Authors:  J A Molina; J Benito-León; F Bermejo; F J Jiménez-Jiménez; J Oliván
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

Review 7.  Sjögren syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  CMAJ       Date:  2014-02-24       Impact factor: 8.262

8.  Parasympathetic failure does not contribute to ocular dryness in primary Sjögren's syndrome.

Authors:  P J Barendregt; A H van Den Meiracker; H M Markusse; J H Tulen; F Boomsma; G L van Der Heijde; A J Veld
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

9.  Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism.

Authors:  Sharon Hassin-Baer; Yair Levy; Pnina Langevitz; Sasson Nakar; Michael Ehrenfeld
Journal:  Clin Rheumatol       Date:  2006-10-21       Impact factor: 2.980

10.  Psychiatric disorder as clinical presentation of primary Sjögren's syndrome: two case reports.

Authors:  Lorenzo Pelizza; Federica Bonacini; Alberto Ferrari
Journal:  Ann Gen Psychiatry       Date:  2010-04-01       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.